Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from AdAlta Ltd. ( (AU:1AD) ).
AdAlta Limited has issued 41,666,667 fully paid ordinary shares to NLSC, LLC as part of its funding arrangements, with each share priced at $0.0018. This move is part of the company’s strategic financial management, ensuring compliance with relevant corporate regulations, and it highlights AdAlta’s ongoing efforts to secure necessary funding for its operations.
More about AdAlta Ltd.
AdAlta Limited is a biotechnology company that focuses on developing innovative therapies using its proprietary i-body technology. The company primarily operates in the healthcare sector, aiming to address unmet medical needs through its unique platform.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.34M
Learn more about 1AD stock on TipRanks’ Stock Analysis page.